Results 301 to 310 of about 7,756,024 (397)

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Addressing genetic discrimination for stronger legal protections and enhanced public awareness. [PDF]

NPJ Genom Med
Takahashi S, Lan T, Toh HJ, Nord-Bronzyk AJ, Teo I, Menon S, Savulescu J, Schaefer O.   +7 more
europepmc   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Unlocking intergenerational support: The impact of long-term care insurance on elderly family dynamics. [PDF]

PLoS One
Qu Y, Li Y, Yin A, Li J.
europepmc   +1 more source

A comparison benefit reserves of an n–year term life insurance between using the vasicek model and cox-ingersoll-ross model

Isti Kamila, Ani Andriyati, Embay Rohaeti   +2 more
openalex   +1 more source

Trends in 25 years of antihypertensive agent utilization in Croatia – an alert for scientific community and healthcare providers

British Journal of Clinical Pharmacology, EarlyView.
Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić, Marta Kučan Štiglić, Ana Jelaković, Bojan Jelaković, Dinko Vitezić   +4 more
wiley   +1 more source

Informal care and cognitive frailty among Chinese older adults: the mediating role of social participation. [PDF]

BMC Geriatr
Gao T, Zhao D, Chai S, Qi X, Liu Y, Sun Y, Zhang Y, Lin Z, Zhou J, Zhou C.   +9 more
europepmc   +1 more source

Integration of job satisfaction into the Personal Wellbeing Index: analysis of psychometric properties and sociodemographic influences among employees of the Croatian Health Insurance Fund. [PDF]

Arh Hig Rada Toksikol
Dubravac J, Barić R.
europepmc   +1 more source

How the Product Structure and Distribution Channels Affect the Business Cycle of the UK Life and General Insurance Companies

, 2019
Michel Guirguis
openalex   +1 more source

When healthcare becomes the barrier to heart transplantation and advanced therapies. [PDF]

Front Cardiovasc Med
Imielski BR, Gilani AS, Khawaja ZR, Pisani BA.   +3 more
europepmc   +1 more source